The CPG Bridge Round Playbook: When to Use a Convertible Note (and When It's a Trap)
SAFEs and convertible notes look simple until they aren't. Jeff Church breaks down when bridge instruments work in CPG fundraising — and when they quietly destroy your cap table.
Here's a conversation I've had probably a dozen times over the last five years.
A founder calls me. Smart person. Great product. Real traction. They'd raised $800,000 from friends and family on a SAFE. Then $1.2 million on a convertible note from a handful of angels eighteen months later. Now they're trying to raise a $3 million seed round from institutional investors and the lead just called to say they have "cap table concerns."
The founder is blindsided. They'd done what everyone told them to do. Raised capital when they needed it. Used the instruments their lawyer suggested. Kept it simple.
The problem? Simple is in the eye of the beholder. What looked clean from the founder's perspective looked like a math problem from the investor's side.
Let me start with the basics, because I meet founders all the time who are using these instruments without fully understanding what they've committed to.
A SAFE (Simple Agreement for Future Equity) gives an investor the right to convert their investment into equity at a future priced round, typically at a discount or with a valuation cap. Not a loan. No interest. No maturity date. A bet that a future round happens.
SAFEs were popularized by Y Combinator. They made sense in a world where software startups raised seed rounds from angels and then Series As from tier-one VCs eighteen months later like clockwork. Clean, fast, light on legal fees.
CPG is not that world.
CPG takes longer. It costs more. The Rule of Twos applies here just like everywhere else... whatever timeline you think you're on, double it. The path from SAFE to priced round in consumer goods is rarely eighteen months. It's often three to four years. And over three to four years, the world changes, your business changes, the investor landscape changes.
When those changes happen, your SAFEs are still sitting there. Waiting to convert. Stacking up on a cap table that gets more complicated with every passing quarter.
A convertible note is similar but it is a loan. It carries an interest rate, typically 6-8% in CPG. It has a maturity date, usually 12-24 months. It converts to equity at a discount to the next round or at a valuation cap, whichever benefits the investor more.
The maturity date is the detail that bites founders. Twelve months goes fast in CPG. If you haven't closed your next round by the time the note matures, you're in default unless you renegotiate. And renegotiating with investors from a position of weakness is a conversation you never want to have.
I've watched founders who thought they were buying time with a bridge note. They were actually setting a deadline.
So when do these instruments actually work? And when do they become problems?
They work when:
The money is bridging a specific, identifiable gap. You're six to nine months from a credible institutional close, with real investor interest already in motion. You're finishing a retail pilot. Hitting the velocity milestone a lead investor needs to see. Closing out a fiscal year with stronger numbers. The bridge investor knows exactly what they're bridging to, and so do you.
They work when your cap table is still relatively clean. A single SAFE or note from a small, aligned group of angels is manageable. Investors who come in after can see exactly what happened, when, and on what terms.
They become traps when:
You stack multiple SAFEs and notes over an extended period without a priced round in sight. I've seen cap tables with six or seven separate bridge instruments at different caps and different discount rates. Every institutional investor who looks at that asks the same question: if the company is doing well, why has it been in bridge mode for three years?
They become traps when you take a note without a valuation cap. No cap means that if your company is worth $20 million at your next priced round, the bridge investor gets priced in at whatever price the new investors set. That sounds fine until the bridge investor realizes they put in money when the company was worth $3 million and they're getting no benefit for taking that early risk. Unhappy investors talk. In CPG, where the investor community is smaller than it looks from the outside, that has consequences.
They become traps when you extend maturity dates instead of closing rounds. One extension is understandable. Two is a pattern. Three looks like a company that can't raise.
And they become traps when you treat bridge capital as a substitute for building a business that can actually attract equity investment. I've seen founders bridge for two or three years without making the fundamental progress that moves them closer to institutional capital. The bridge becomes life support, not a tactical tool.
Here's the framework I walk founders through before they issue another instrument.
Map the conversion math before you issue anything. If your SAFE has a $5 million valuation cap and you raise your next round at a $12 million pre-money valuation, your SAFE converts at the cap. That's effectively a 58% premium to the round price for the bridge investor. For a $200,000 SAFE, that means you're issuing roughly $480,000 worth of equity. What percentage of the company does that represent? Does your model account for that dilution?
Do this math for every instrument on your cap table before you talk to a new investor. If you can't show an institutional investor a clear picture of post-money ownership at your target raise amount, you're not ready to raise.
Keep it simple and keep the group small. The best bridge rounds I've seen have three to five investors who are already aligned with the company's direction, understand CPG timelines, and know they're acting as bridge capital ahead of a specific institutional round. They know what they're getting into. They're not expecting venture returns. They're supporting the company through a defined window.
When bridge rounds involve fifteen or twenty investors at different check sizes, different caps, different discount rates, different expectations... that's when institutional investors start questioning whether the founder can manage a real cap table.
Use a SAFE for early pre-traction capital. Use a note for a specific bridge. This isn't a law, but it's a framework I find useful. The SAFE is better suited for the earliest stage, before you have much to underwrite. The convertible note is better suited once you have traction and you're bridging to a known event. The maturity date creates accountability that a SAFE doesn't. Sometimes that pressure is exactly what a company needs.
Get the cap right. The valuation cap on a SAFE or note is essentially the implied price of the bridge round. Set it too low and you're giving away equity cheaply. Set it too high and your bridge investors feel burned if your next round doesn't justify it.
I generally advise founders to set the cap at 1.5x to 2x what you believe the current fair value of the business is. Enough of a discount to make the risk worthwhile for investors. Not so generous that you've created a problem for yourself at the next round.
Always get a discount rate, even if you have a cap. Standard is 15-20%. The discount protects your bridge investors in scenarios where the round comes in above the cap. They should be rewarded for taking early risk. Treat them fairly and they'll tell the next generation of investors how you handled things when you didn't have to.
There's one thing I want to be direct about, because it doesn't get said enough.
Fundraising is not proof that you're winning. It's table stakes to stay in the game.
Every bridge round buys time. But time only matters if you're using it to build something that can attract real equity capital on the other side. If you're raising another note to extend another note to extend another note, at some point you have to ask the harder question: is this business actually on a path to institutional capital? Or am I extending a timeline that doesn't lead anywhere?
I've been involved in forty-four fundraising rounds across eight companies. I've seen bridges that worked exactly as intended and ones that nearly killed good companies. The difference was almost always clarity of purpose. The founders who used bridge capital strategically knew precisely what the money was buying, exactly what milestone they were hitting, and exactly who they'd be talking to when the bridge ended.
The founders who used it to avoid hard questions... those conversations never went well.
One more thing on terms that founders don't ask about early enough.
Most favored nation (MFN) clauses allow a bridge investor to upgrade to the terms of any subsequent bridge instrument if those terms are more favorable. Sounds harmless until you issue a second note with a higher cap to close a gap, and your MFN investor immediately upgrades to the better deal. This is a provision that experienced angels push for, and it's worth understanding what you're agreeing to before you sign it.
Information rights. Some bridge notes include provisions requiring you to share quarterly financials. That's not necessarily bad... investors who have information rights tend to be more supportive and engaged. But it does mean more administrative work at an early stage. Decide intentionally whether you want that.
Pro-rata rights on future rounds. Many bridge investors ask for the right to participate in future rounds to maintain their ownership percentage. In isolation, that's a fair ask. But if you have twelve bridge instruments and every investor has pro-rata rights, you've potentially committed a significant portion of your next round before you've even started talking to new investors. Understand the cumulative math.
Dream boldly. Plan soberly.
That's the principle I come back to constantly, and it applies here more than almost anywhere else in the fundraising process. When you're structuring bridge instruments, the "plan soberly" part matters most. Be honest about where you are. Be honest about what the bridge is buying. Be honest about what has to happen for you to raise a real round on the other side.
Founders who oversell their position to bridge investors, who promise timelines that were never realistic, who imply institutional interest that doesn't exist... those founders end up explaining themselves to unhappy people. In CPG, where the community is tight and relationships carry for a long time, that matters.
Bridge wisely. Build relentlessly. And remember that the only bridge that matters is the one that leads to a business that can stand on its own.
Jeff Church's MBA for CPG is the most comprehensive program available for founders navigating fundraising, growth, and real exit readiness. The 90-Day Breakthrough Program is built for founders who need a structured path forward — right now.
Want more insights like this?
Get Jeff’s take on what’s actually working in CPG. Direct to your inbox.